502133-49-5 (4-(3-羧基-2-吡啶)-[1,4]二氮杂卓-1-羧酸叔丁酯,3-Pyridinecarboxylicacid, 2-(hexahydro-1H-1,4-diazepin-1-yl)-)

4-(3-羧基-2-吡啶)-[1,4]二氮杂卓-1-羧酸叔丁酯;

3-Pyridinecarboxylicacid, 2-(hexahydro-1H-1,4-diazepin-1-yl)-;4-(3-CARBOXY-PYRIDIN-2-YL)-[1,4]DIAZEPANE-1-CARBOXYLIC ACID TERT-BUTYL ESTER;1H-1,4-diazepine-1-carboxylic acid, 4-(3-carboxy-2-pyridinyl)hexahydro-, 1-(1,1-dimethylethyl) ester;2-(4-{[(2-Methyl-2-propanyl)oxy]carbonyl}-1,4-diazepan-1-yl)nicotinic acid;2-[4-(tert-Butoxycarbonyl)-1,4-diazepan-1-yl]nicotinic acid;AKOS005257417;MFCD06245564;2-[4-[(2-methylpropan-2-yl)oxycarbonyl]-1,4-diazepan-1-yl]pyridine-3-carboxylic Acid;4-(3-Carboxy-pyridin-2-yl)-[1,4]diazepane-1-carboxylic acid tert-butyl ester, AldrichCPR;3-Pyridinecarboxylicacid,2-(hexahydro-1H-1,4-diazepin-1-yl)-;4-(3-Carboxypyridin-2-yl)-[1,4]diazepane-1-carboxylic acid tert-butyl ester;2-{4-[(tert-Butoxy)carbonyl]-1,4-diazepan-1-yl}pyridine-3-carboxylic acid;2-(4-(tert-Butoxycarbonyl)-1,4-diazepan-1-yl)nicotinicacid;502133-49-5;

MFCD06245564

VNNVAWDHPDFXLR-UHFFFAOYSA-N

1S/C16H23N3O4/c1-16(2,3)23-15(22)19-9-5-8-18(10-11-19)13-12(14(20)21)6-4-7-17-13/h4,6-7H,5,8-11H2,1-3H3,(H,20,21)

O(C(C)(C)C)C(N1CCN(C2C(C(=O)O)=CC=CN=2)CCC1)=O

2933990090